Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Beovu Label Change: Novartis Adds Information, Increases Safety Warnings in February 2022

February 25, 2022 By Law Offices of Thomas J. Lamb, P.A.

We had been watching for a second Beovu label change since May 2021, when Novartis stopped three Beovu clinical trials for safety reasons, and, at the same time, said it would update the Beovu drug label. Finally, in February 2022, Novartis added information and increased safety warnings about various Beovu eye-related side effects, such as retinal … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, retinal vascular occlusion, retinal vasculitis, vision loss

Beovu Drug Label Revised December 2021 Was Issued in Europe, But Not in the US

January 22, 2022 By Law Offices of Thomas J. Lamb, P.A.

A “new” Beovu drug label which was revised in December 2021 sets forth some additional information about the vision-related Beovu side effects intraocular inflammation, retinal vasculitis, and retinal vascular occlusion. We point out, however, that there was no similar 2021 Beovu label change issued by Novartis in the US. From this Drug Safety … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, intraocular inflammation, occlusive retinal vasculitis, retinal vascular occlusion, retinal vasculitis, vision loss

Beovu: Rates of Intraocular Inflammation and Retinal Vascular Occlusion

December 22, 2021 By Law Offices of Thomas J. Lamb, P.A.

A November 2021 article published by the medical journal JAMA Ophthalmology, “Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration”, provides new information about the incidence rates of intraocular inflammation and retinal vascular occlusion associated with Beovu (brolucizumab). This is our 19th article about Beovu … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, intraocular inflammation, retinal vascular occlusion, vision loss

Beovu Lawsuits Lawyer / Law Firm Handles Individuals’ Cases, Not Beovu Class Actions

March 11, 2021 By Law Offices of Thomas J. Lamb, P.A.

We want to clear up some possible confusion. If a patient has vision loss or blindness after getting Beovu injections in their eyes, this person must contact a lawyer or law firm to handle their Beovu case in order to get legal compensation for the Beovu drug injury they have suffered. That is because Beovu lawsuits are being filed as individual … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, occlusive retinal vasculitis, retinal artery occlusion, retinal vascular occlusion, retinal vasculitis, vision loss

Beovu: What Comes Next for This Troubled Novartis AMD Eye Injection?

January 11, 2021 By Law Offices of Thomas J. Lamb, P.A.

As we start 2021, let’s look at where things currently stand with the Beovu “safety issue” — Beovu adverse drug reactions and Beovu-related eye problems — and how we got here. In the 15 months since Beovu was approved by the FDA in October 2019, there have been numerous reports of Beovu causing occlusive retinal vasculitis, retinal artery … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, intraocular inflammation, occlusive retinal vasculitis, retinal artery occlusion, retinal vascular occlusion, retinal vasculitis, vision loss

Beovu Injections Side Effects: Novartis Points Out Risk Factors and Possible Causes in November 2020 Report

November 19, 2020 By Law Offices of Thomas J. Lamb, P.A.

In mid-November 2020 Novartis addressed the root causes and potential risk factors for Beovu patients developing vision loss by releasing some findings by its experts examining these adverse events associated with Beovu injections. From this November 14, 2020, Reuters new report, “Novartis identifies possible risk factors for Beovu … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, retinal vascular occlusion, retinal vasculitis, vision loss

Safety of Beovu Update: Study Results Announcement by Novartis and Beovu Label Change in Europe

September 24, 2020 By Law Offices of Thomas J. Lamb, P.A.

A September 2020 announcement by Novartis about recent Beovu study results had an emphasis on the safety of Beovu. However, this is understandable in view of a February 2020 notification issued by the American Society of Retina Specialists (ASRS) which raised questions about the safety of Beovu. We get the following from this September 14, … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, intraocular inflammation, retinal vascular occlusion, retinal vasculitis, vision loss

Beovu: External Safety Review Committee Findings Lead To New Vision-Related Side Effects Warnings

July 9, 2020 By Law Offices of Thomas J. Lamb, P.A.

First, Novartis set up an internal review of Beovu vision-related side effects observed in the HAWK & HARRIER clinical trials, including rare post-marketing safety reports of vasculitis. In turn, new warnings for Beovu eye injections about retinal vasculitis and retinal vascular occlusion were added to the Beovu drug label. We take a closer … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, intraocular inflammation, occlusive retinal vasculitis, retinal vascular occlusion, retinal vasculitis, vision loss

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.